Tag

sequenziario- Pagina 2

5 minuti di lettura

Pharming announces US FDA approval of Joenja® (leniolisib) as the first and only treatment indicated for APDS

(Adnkronos) – APDS (activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome) is a rare and progressive primary immunodeficiency Joenja® is a targeted treatment of APDS for adult and pediatric patients 12 years of age

Immediapress

CHMP ISSUES POSITIVE OPINION FOR FUTIBATINIB FOR THE TREATMENT OF ADULTS WITH CHOLANGIOCARCINOMA

(Adnkronos) – ZUG, Switzerland, April 27, 2023 /PRNewswire/ — Taiho Oncology Europe GmbH and Taiho Pharmaceutical Co., Ltd. announced today that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending

Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease

Immediapress

(Adnkronos) – TAMPA, Fla., May 1, 2023 /PRNewswire/ — The US FDA has granted an Investigational Device Exemption (IDE) approval for Concept Medical Inc’s novel

Concept Medical granted Investigational Device Exemption (IDE) approval for their Magic Touch Sirolimus Coated Balloon for the treatment of Below the Knee (BTK) Arterial Disease

Immediapress

(Adnkronos) – TAMPA, Fla., Feb. 13, 2023 /PRNewswire/ — Concept Medical Inc. (CMI), on 9thFebruary 2023, received the Investigational Device Exemption (IDE) from the US FDA,

Alphyn Biologics Reports Encouraging Interim Results of Phase 2a Trial for Atopic Dermatitis with Secondary Bacterial Infection

venerdì, 14 Luglio 2023

Immediapress

(Adnkronos) – Topical treatment is achieving all endpoints for efficacy and safety in mild, moderate, and severe atopic dermatitis ANNAPOLIS, Md. and ASHEVILLE, N.C., July 14, 2023 /PRNewswire/ — Alphyn Biologics, a clinical-stage

Study Proves iTind Treatment for Enlarged Prostate Lasts More than Four Years

giovedì, 13 Luglio 2023

Immediapress

(Adnkronos) – HAMBURG, Germany, July 13, 2023 /PRNewswire/ — Olympus Corporation, a global medical technology company, announced publication of study data demonstrating that the minimally invasive iTind™ treatment provides long-lasting relief of more than

Race executes global license agreement with City of Hope to access FTO IP

lunedì, 10 Luglio 2023

Immediapress

(Adnkronos) – SYDNEY, July 10, 2023 /PRNewswire/ — Race Oncology Limited (“Race”) is pleased to announce execution of an exclusive licence agreement (“Agreement”) to access U.S. cancer research and treatment organisation City of

European Commission Grants Conditional Marketing Authorization for Taiho’s LYTGOBI® Tablets for the Treatment of Adults With Cholangiocarcinoma

martedì, 4 Luglio 2023

Immediapress

(Adnkronos) – LYTGOBI is the first irreversibly binding FGFR inhibitor in the European Union for use in the treatment of patients with cholangiocarcinoma ZUG, Switzerland, July 4, 2023 /PRNewswire/ — Taiho Oncology

Concept Medical’s fourth IDE approval for the MagicTouch Sirolimus Coated Balloon is granted for the treatment of Superficial Femoral Artery Disease (SFA)

lunedì, 29 Maggio 2023

Immediapress

(Adnkronos) – TAMPA, Fla., May 29, 2023 /PRNewswire/ — The US FDA, on the 24th of May 2023, granted an Investigational Device Exemption (IDE) approval for Concept Medical Inc’s Sirolimus Coated Balloon (SCB)

Tianlong Helps Hospitals in Thailand Detect Hepatitis Early with Molecular Diagnostic Solution

giovedì, 25 Maggio 2023

Immediapress

(Adnkronos) – XI’AN, China, May 25, 2023 /PRNewswire/ — Tianlong, an innovative high-tech company specializing in molecular diagnostic products in China, has partnered with public hospitals in northern Thailand to build up

New Expert Guidelines from IWGDF Highlight the Growing International Recognition of Topical Oxygen Therapy for Diabetic Foot Ulcers

mercoledì, 17 Maggio 2023

Immediapress

(Adnkronos) – Evidence-based recommendations support the effective use of TOT in diabetic foot ulcer management, revolutionizing treatment approaches worldwide CAMBRIDGE, England, May 17, 2023 /PRNewswire/ — NATROX® Wound Care, a leading innovator

Yuyu Pharma unveiled the results of its mechanism of action and head-to- head studies for its dry eye treatment peptide

giovedì, 27 Aprile 2023

Immediapress

(Adnkronos) – SEOUL, South Korea, April 27, 2023 /PRNewswire/ — At ARVO 2023, Yuyu Pharma unveiled the results of its mechanism of action and head-to-head studies for its dry eye treatment peptide

Results from the first clinical pilot study using maternal spindle transfer indicate that the technique may have value as a treatment for challenging types of infertility and reveal potential limitations when the method is used for avoidance of mitochondrial disorders

venerdì, 17 Marzo 2023

Immediapress

(Adnkronos) – ATHENS, Greece, March 17, 2023 /PRNewswire/ — The results from the first clinical pilot study of maternal spindle transfer (MST) were published online in the journal, Fertility and Sterility, as an

Investigational study provides evidence that recombinant endolysin XZ.700* is a promising novel non-antibiotic treatment strategy aimed at controlling Staphylococcus aureus (S. aureus) colonization of lesional skin in Cutaneous T-cell lymphoma (CTCL).

martedì, 7 Marzo 2023

Immediapress

(Adnkronos) – Research shows XZ.700* could block tumor promoting effects of S. aureus on malignant T cells, potentially delaying tumor progression. Findings strengthen potential of Micreos’ endolysin technology to address unmet patient

Indietro 1 2

sequenziario- Pagina 2

Pharming announces US FDA approval of Joenja® (leniolisib) as the first and only treatment indicated for APDS

CHMP ISSUES POSITIVE OPINION FOR FUTIBATINIB FOR THE TREATMENT OF ADULTS WITH CHOLANGIOCARCINOMA

Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease

Concept Medical granted Investigational Device Exemption (IDE) approval for their Magic Touch Sirolimus Coated Balloon for the treatment of Below the Knee (BTK) Arterial Disease

Alphyn Biologics Reports Encouraging Interim Results of Phase 2a Trial for Atopic Dermatitis with Secondary Bacterial Infection

Study Proves iTind Treatment for Enlarged Prostate Lasts More than Four Years

Race executes global license agreement with City of Hope to access FTO IP

European Commission Grants Conditional Marketing Authorization for Taiho’s LYTGOBI® Tablets for the Treatment of Adults With Cholangiocarcinoma

Concept Medical’s fourth IDE approval for the MagicTouch Sirolimus Coated Balloon is granted for the treatment of Superficial Femoral Artery Disease (SFA)

Tianlong Helps Hospitals in Thailand Detect Hepatitis Early with Molecular Diagnostic Solution

New Expert Guidelines from IWGDF Highlight the Growing International Recognition of Topical Oxygen Therapy for Diabetic Foot Ulcers

Yuyu Pharma unveiled the results of its mechanism of action and head-to- head studies for its dry eye treatment peptide

Results from the first clinical pilot study using maternal spindle transfer indicate that the technique may have value as a treatment for challenging types of infertility and reveal potential limitations when the method is used for avoidance of mitochondrial disorders

Investigational study provides evidence that recombinant endolysin XZ.700* is a promising novel non-antibiotic treatment strategy aimed at controlling Staphylococcus aureus (S. aureus) colonization of lesional skin in Cutaneous T-cell lymphoma (CTCL).

Primo piano

CdM approva decreto urgente per autotrasporto, agricoltura e pesca. Meloni: “Non tolleriamo intimidazioni” | Video

Il prete che ha mostrato il dito medio ai ragazzi durante i disordini a Milano: «Pentito? No, ho solo risposto»

Italia-Spagna, la sospensione di Schengen non sarà rinnovata

Blocco Tir, governo “sblocca” in Sicilia e Calabria, ma il Golfo di Napoli a rischio isolamento

Dopo gli scontri: cosa prevede il decreto e quali poteri hanno i militari

Sponsor

Suggerimenti

sequenziario- Pagina 2

Primo piano

Sponsor